For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found ...

What Benefits of Jaypirca Were Seen in the Studies for People with Chronic Lymphocytic Leukemia? People with CLL in the BRUIN trial who were previously treated with a BTK inhibitor benefited ...

During a Case-Based Roundtable® event, Ryan W. Jacobs, MD, discussed a patient who received 2 prior lines of therapy for ...

Investigators found that lipid metabolism disruptions spark T-cell dysfunction in patients with chronic lymphocytic leukemia.

The following is a summary of "BCL-2 dependence is a favorable predictive marker of response to therapy for chronic ...

SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.

But my blood smear showed smudge cells, a hallmark of chronic lymphocytic leukemia—CLL. Like most people diagnosed with CLL, I had no symptoms to suggest cancer. Despite quickly catching up on the ...

Eli Lilly (NYSE:LLY) recently announced several significant events, including promising trial results for baricitinib in ...

A study in Cancer compared the accuracy of five risk scores for time to treatment in CLL, including the IPS-E, CR0, AIPS-E, ...

Learn the essential early warning signs of leukemia that are often dismissed as everyday ailments but could be indicators of ...

Black women with chronic myeloid leukemia face unique challenges when it comes to diagnosis, treatment, and overall disease ...